Clinical relevance of novel biomarkers for tau and a-synuclein pathology

In this project we develop and validate novel biomarkers, especially in blood, for measuring either tau pathology in Alzheimer’s disease or Lewy body pathology in Parkinson’s disease and dementia with Lewy bodies.